These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T. Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104 [Abstract] [Full Text] [Related]
4. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A. Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664 [Abstract] [Full Text] [Related]
5. How do statins work?: changing paradigms with implications for statin allocation. Blaha MJ, Martin SS. J Am Coll Cardiol; 2013 Dec 24; 62(25):2392-2394. PubMed ID: 24067403 [No Abstract] [Full Text] [Related]
6. Statins and periodontal inflammation: a pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering? Norata GD, Catapano AL. Atherosclerosis; 2014 Jun 24; 234(2):381-2. PubMed ID: 24747112 [No Abstract] [Full Text] [Related]
13. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN, REVERSAL Investigators. JAMA; 2004 Mar 03; 291(9):1071-80. PubMed ID: 14996776 [Abstract] [Full Text] [Related]
15. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Rawlings R, Nohria A, Liu PY, Donnelly J, Creager MA, Ganz P, Selwyn A, Liao JK. Am J Cardiol; 2009 Feb 15; 103(4):437-41. PubMed ID: 19195498 [Abstract] [Full Text] [Related]